Discovery of a New STAT3 Inhibitor Acting on the Linker Domain
Tatsuya Koseki(University of Shizuoka), Akira Asai(University of Shizuoka)
Cited by 13
Related Papers
Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance
|Journal of Clinical Investigation|2019|143
Inhibition of STAT3 by Anticancer Drug Bendamustine
|PLoS ONE|2017|16
Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines
|Scientific Reports|2021|12
Visualization and quantification of dynamic STAT3 homodimerization in living cells using homoFluoppi
|Scientific Reports|2018|11